The transmission of tuberculosis in the light of new molecular biological approaches

Por Seidler, A, Nienhaus, A, Diel, R
Publicado em 2004

Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany

Por Diel, R., Obradovic, M., Tyler, S., Engelhard, J., Kostev, K.
Publicado no J Clin Tuberc Other Mycobact Dis (2020)

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons

Por Meywald-Walter K, Lange C, Nienhaus A, Diel R, Forßbohm M, Schaberg T
Publicado em 2006-05-01

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons

Por Diel, R, Nienhaus, A, Lange, C, Meywald-Walter, K, Forßbohm, M, Schaberg, T
Publicado em 2006

The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study

Por Goring, S. M., Wilson, J. B., Risebrough, N. R., Gallagher, J., Carroll, S., Heap, K. J., Obradovic, M., Loebinger, M. R., Diel, R.
Publicado no BMC Health Serv Res (2018)

The Species Mycobacterium africanum in the Light of New Molecular Markers

Por Niemann, S., Kubica, T., Bange, F. C., Adjei, O., Browne, E. N., Chinbuah, M. A., Diel, R., Gyapong, J., Horstmann, R. D., Joloba, M. L., Meyer, C. G., Mugerwa, R. D., Okwera, A., Osei, I., Owusu-Darbo, E., Schwander, S. K., Rüsch-Gerdes, S.
Publicado em 2004